Recent Advancements in Metallic Au- and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery

• Published in: Molecules (Basel, Switzerland) Switzerland), 2024-05, Vol.29 (10), p.2393
• Main Authors: El-Meligy, Mahmoud A, Abd El-Monaem, Eman M, Eltaweil, Abdelazeem S, Mohy-Eldin, Mohamed S, Ziora, Zyta M, Heydari, Abolfazl, Omer, Ahmed M
• Format: Article
• Language: English
• Subjects: Animals; Antineoplastic Agents - administration & dosage; Antineoplastic Agents - chemistry; Antineoplastic Agents - pharmacology; Bioavailability; Biopolymers; Cancer therapies; cancer therapy; Cell division; chitosan; Chitosan - chemistry; Drug Carriers - chemistry; drug delivery; Drug Delivery Systems; Drug dosages; Drug resistance; Drugs; gold; Gold - chemistry; Health aspects; Humans; Metal Nanoparticles - chemistry; nanocomposite; Nanocomposites; Nanocomposites - chemistry; Nanoparticles; Nanotechnology; Neoplasms - drug therapy; Permeability; Pharmaceuticals; Polysaccharides; silver; Silver - chemistry; Toxicity; Tumors; Vehicles
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules29102393

The rapid advancements in nanotechnology in the field of nanomedicine have the potential to significantly enhance therapeutic strategies for cancer treatment. There is considerable promise for enhancing the efficacy of cancer therapy through the manufacture of innovative nanocomposite materials. Metallic nanoparticles have been found to enhance the release of anticancer medications that are loaded onto them, resulting in a sustained release, hence reducing the dosage required for drug administration and preventing their buildup in healthy cells. The combination of nanotechnology with biocompatible materials offers new prospects for the development of advanced therapies that exhibit enhanced selectivity, reduced adverse effects, and improved patient outcomes. Chitosan (CS), a polysaccharide possessing distinct physicochemical properties, exhibits favorable attributes for controlled drug delivery due to its biocompatibility and biodegradability. Chitosan nanocomposites exhibit heightened stability, improved biocompatibility, and prolonged release characteristics for anticancer medicines. The incorporation of gold (Au) nanoparticles into the chitosan nanocomposite results in the manifestation of photothermal characteristics, whereas the inclusion of silver (Ag) nanoparticles boosts the antibacterial capabilities of the synthesized nanocomposite. The objective of this review is to investigate the recent progress in the utilization of Ag and Au nanoparticles, or a combination thereof, within a chitosan matrix or its modified derivatives for the purpose of anticancer drug delivery. The research findings for the potential of a chitosan nanocomposite to deliver various anticancer drugs, such as doxorubicin, 5-Fluroacil, curcumin, paclitaxel, and 6-mercaptopurine, were investigated. Moreover, various modifications carried out on the chitosan matrix phase and the nanocomposite surfaces to enhance targeting selectivity, loading efficiency, and pH sensitivity were highlighted. In addition, challenges and perspectives that could motivate further research related to the applications of chitosan nanocomposites in cancer therapy were summarized.